Jazz Pharmaceuticals plc 2013 Executive Officer Compensation Arrangements
Contract Categories:
Human Resources
›
Compensation Agreements
Summary
This document outlines the 2013 compensation arrangements for executive officers of Jazz Pharmaceuticals plc. It lists the base salary rates and target bonus percentages for each executive, effective as of March 1, 2013. The target bonus is calculated as a percentage of the annual base salary and varies by position and responsibility. The agreement ensures transparency in executive pay and sets clear compensation expectations for the company's top management team.
EX-10.6 2 jazzq12013ex106.htm JAZZ PHARMACEUTICALS PLC 2013 EXECUTIVE OFFICER COMPENSATION ARRANGEMENTS JAZZ Q1 2013 EX 10.6
Exhibit 10.6
2013 Executive Officer Compensation Arrangements
Executive Officer | Base Salary Rate(1) | Target Bonus as % of Annual Base Salary Rate(2) |
Bruce C. Cozadd Chairman and Chief Executive Officer | $775,000 | 100 |
Kathryn E. Falberg Executive Vice President and Chief Financial Officer | $475,000 | 50 |
Russell J. Cox Executive Vice President and Chief Commercial Officer | $425,000 | 50 |
Suzanne Sawochka Hooper Executive Vice President and General Counsel | $475,000 | 50 |
Fintan Keegan Executive Vice President, Technical Operations | €270,000 | 50 |
Jeffrey K. Tobias, M.D. Executive Vice President, Research and Development and Chief Medical Officer | $425,000 | 50 |
Karen J. Wilson Senior Vice President, Finance and Principal Accounting Officer | $285,000 | 40 |
(1) | Base salary rate effective beginning by March 1, 2013. |
(2) | Target bonus percentage for each officer is based on his or her position and/or responsibility level as provided in Jazz Pharmaceuticals plc’s cash bonus plans. |
